Is breast cancer prognosis inherited?

Breast Cancer Research

Volumn 9, Issue 3, 2007, Pages

  Hartman, Mikael ^a,b   Lindström, Linda ^a   Dickman, Paul W ^a   Adami, Hans Olov ^a,c   Hall, Per ^a   Czene, Kamila ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DAUGHTER; FEMALE; FOLLOW UP; GENETIC TRAIT; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MOTHER; OUTCOME ASSESSMENT; PROGNOSIS; SURVIVAL RATE; SWEDEN; BREAST TUMOR; GENETICS; MIDDLE AGED; MORTALITY; NUCLEAR FAMILY; PATHOPHYSIOLOGY; REGISTER; SURVIVAL; SURVIVOR; TIME;

ADULT; AGED; BREAST NEOPLASMS; CAUSE OF DEATH; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NUCLEAR FAMILY; PROGNOSIS; REGISTRIES; SURVIVAL ANALYSIS; SURVIVORS; SWEDEN; TIME FACTORS;

EID: 34548562466     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1737     Document Type: Article

References (38)

1. Czene K Lichtenstein P Hemminki K: Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer 2002, 99:260-266. 10.1002/ijc.10332 11979442
2. Lichtenstein P Holm NV Verkasalo PK Iliadou A Kaprio J Koskenvuo M Pukkala E Skytthe A Hemminki K: Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000, 343:78-85. 10.1056/ NEJM200007133430201 10891514
3. Chappuis PO Rosenblatt J Foulkes WD: The influence of familial and hereditary factors on the prognosis of breast cancer. Ann Oncol 1999, 10:1163-1170. 10.1023/A:1008301314812 10586331
4. Thalib L Wedren S Granath F Adami HO Rydh B Magnusson C Hall P: Breast cancer prognosis in relation to family history of breast and ovarian cancer. Br J Cancer 2004, 90:1378-1381. 10.1038/sj.bjc.6601694 15054458
5. Veronesi A de Giacomi C Magri MD Lombardi D Zanetti M Scuderi C Dolcetti R Viel A CrivellarC D Bidoli E: Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases. BMC Cancer 2005, 5:70. 1184063 15996267 10.1186/1471-2407-5-70
6. Stoppa-Lyonnet D Ansquer Y Dreyfus H Gautier C Gauthier-Villars M Bourstyn E Clough KB Magdelenat H Pouillart P Vincent-Salomon A: Familial invasive breast cancers: Worse outcome related to BRCA1 mutations. J Clin Oncol 2000, 18:4053-4059. 11118466
7. Brekelmans CT Seynaeve C Menke-Pluymers M Bruggenwirth HT Tilanus-Linthorst MM Bartels CC Kriege M van Geel AN Crepin CM Blom JC: Survival and prognostic factors in BRCA1-associated breast cancer. Ann Oncol 2006, 17:391-400. 10.1093/annonc/mdj095 16322115
8. Lambe M Hsieh CC Chan HW Ekbom A Trichopoulos D Adami HO: Parity, age at first and last birth, and risk of breast cancer: A population-based study in Sweden. Breast Cancer Res Treat 1996, 38:305-311. 10.1007/ BF01806150 8739084
9. Bergkvist L Adami HO Persson I Hoover R Schairer C: The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 1989, 321:293-297. 2546079
10. Hankinson S Hunter D: Breast cancer. A Textbook of Cancer Epidemiology New York, NY: Oxford University Press, Inc Adami HO, Hunter D, Trichopolous D 2002.
11. Rosenberg L Thalib L Adami HO Hall P: Childbirth and breast cancer prognosis. Int J Cancer 2004, 111:772-776. 10.1002/ijc.20323 15252849
12. Schairer C Gail M Byrne C Rosenberg PS Sturgeon SR Brinton LA Hoover RN: Estrogen replacement therapy and breast cancer survival in a large screening study. J Natl Cancer Inst 1999, 91:264-270. 10.1093/jnci/ 91.3.264 10037105
13. Chlebowski RT Aiello E McTiernan A: Weight loss in breast cancer patient management. J Clin Oncol 2002, 20:1128-1143. 10.1200/JCO.20.4.1128 11844838
14. Statistics Sweden: The Multi-Generation Register Örebro, Sweden; 2001.
15. Mattsson B Wallgren A: Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984, 23:305-313. 6095600
16. Larsson LG Nystrom L Wall S Rutqvist L Andersson I Bjurstam N Fagerberg G Frisell J Tabar L: The Swedish randomised mammography screening trials: Analysis of their effect on the breast cancer related excess mortality. J Med Screen 1996, 3:129-132. 8946307
17. SAS Institute: SAS/STAT User's Guide. Version 8.2 Cary, NC: SAS Institute, Inc; 1999.
18. Elmore JG Armstrong K Lehman CD Fletcher SW. Screening for breast cancer. JAMA 2005, 293:1245-1256. 10.1001/jama.293.10.1245 15755947
19. Rutqvist LE Bern A: Socioeconomic gradients in clinical stage at presentation and survival among breast cancer patients in the Stockholm area 1977-1997. Int J Cancer 2006, 119:1433-1439. 10.1002/ijc.21949 16596647
20. Lagerlund M Bellocco R Karlsson P Tejler G Lambe M: Socio-economic factors and breast cancer survival - a population-based cohort study (Sweden). Cancer Causes Control 2005, 16:419-430. 10.1007/ s10552-004-6255-7 15953984
21. Collett K Stefansson IM Eide J Braaten A Wang H Eide GE Thoresen SO Foulkes WD Akslen LA: A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev 2005, 14:1108-1112. 10.1158/ 1055-9965.EPI-04-0394 15894660
22. McTiernan A Martin CF Peck JD Aragaki AK Chlebowski RT Pisano ED Wang CY Brunner RL Johnson KC Manson JE: Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's health initiative randomized trial. J Natl Cancer Inst 2005, 97:1366-1376. 16174858
23. Ziv E Shepherd J Smith-Bindman R Kerlikowske K: Mammographic breast density and family history of breast cancer. J Natl Cancer Inst 2003, 95:556-558. 12671024
24. Kriege M Brekelmans CT Peterse H Obdeijn IM Boetes C Zonderland HM Muller SH Kok T Manoliu RA Besnard AP: Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer. Breast Cancer Res Treat 2007, 102:357-363. 10.1007/s10549-006-9341-6 17051427
25. Cabrera C Helgesson O Wedel H Bjorkelund C Bengtsson C Lissner L: Socioeconomic status and mortality in Swedish women: Opposing trends for cardiovascular disease and cancer. Epidemiology 2001, 12:532-536. 10.1097/00001648-200109000-00012 11505172
26. Gapstur SM Morrow M Sellers TA: Hormone replacement therapy and risk of breast cancer with a favorable histology: Results of the Iowa Women's Health Study. JAMA 1999, 281:2091-2097. 10.1001/jama.281.22.2091 10367819
27. Fowble B Hanlon A Freedman G Patchefsky A Kessler H Nicolaou N Hoffman J Sigurdson E Boraas M Goldstein L: Postmenopausal hormone replacement therapy: Effect on diagnosis and outcome in early-stage invasive breast cancer treated with conservative surgery and radiation. J Clin Oncol 1999, 17:1680-1688. 10561204
28. Anderson K Jacobson JS Heitjan DF Zivin JG Hershman D Neugut AI Grann VR: Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation. Ann Intern Med 2006, 144:397-406. 16549852
29. Loman N Johannsson O Kristoffersson U Olsson H Borg A: Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst 2001, 93:1215-1223. 10.1093/jnci/93.16.1215 11504767
30. Nowell SA Ahn J Rae JM Scheys JO Trovato A Sweeney C MacLeod SL Kadlubar FF Ambrosone CB: Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients. Breast Cancer Res Treat 2005, 91:249-258. 10.1007/s10549-004-7751-x 15952058
31. Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005, 365:1687-1717. 10.1016/S0140-6736(05)66544-0 15894097
32. Choi JY Nowell SA Blanco JG Ambrosone CB: The role of genetic variability in drug metabolism pathways in breast cancer prognosis. Pharmacogenomics 2006, 7:613-624. 10.2217/14622416.7.4.613 16753008
33. Hunter KW Broman KW Voyer TL Lukes L Cozma D Debies MT Rouse J Welch DR: Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1. Cancer Res 2001, 61:8866-8872. 11751410
34. Hunter K Welch DR Liu ET: Genetic background is an important determinant of metastatic potential. Nat Genet 2003, 34:23-24. author reply 25 10.1038/ng0503-23b 12721549
35. Cozma D Lukes L Rouse J Qiu TH Liu ET Hunter KW: A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers. Genome Res 2002, 12:969-975. 1383737 12045150 10.1101/gr.210502
36. Qiu TH Chandramouli GV Hunter KW Alkharouf NW Green JE Liu ET: Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: Correlation to human disease. Cancer Res 2004, 64:5973-5981. 10.1158/0008-5472.CAN-04-0242 15342376
37. Goode EL Dunning AM Kuschel B Healey CS Day NE Ponder BA Easton DF Pharoah PP: Effect of germ-line genetic variation on breast cancer survival in a population-based study. Cancer Res 2002, 62:3052-3057. 12036913
38. Crawford NP Ziogas A Peel DJ Hess J Anton-Culver H Hunter KW: Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer. Breast Cancer Res 2006, 8:R16. 1483843 16563182 10.1186/bcr1389